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Abstract
Acidification of stratum corneum prevents atopic march 
in murine models
Hae-Jin Lee
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Eung Ho Choi)
Maintenance of acidic pH in the stratum corneum(SC) is an important factor for normal 
skin barrier function. Long standing or repeated skin barrier damage followed by atopic 
dermatitis(AD) is the initial step of the atopic march that eventually progresses to 
respiratory allergies. We determined whether various AD murine models, flaky tail, 
Nc/Nga and multiple oxazolone(Ox) challenged mice, can develop airway inflammation 
by topical application and nasal inhalation of a house dust mite, Dermatofagoides 
pteronyssinus(Dp)(defined as a novel ‘atopic march animal model’), and whether 
maintenance of an acidic SC environment by continuous application of acidic cream can 
interrupt this atopic march. During the course of Dp treatment to the atopic march murine 
model, an acidic cream with pH 2.8 and neutral cream(pH7.4) adjusted by citric acid and 
sodium hydroxide mixed with vehicle were applied twice daily. Repeated applications 
viii
and inhalations of Dp to AD murine model induced AD skin lesions followed by 
respiratory allergies. These results indicate that novel atopic march models can be 
developed by repeated application of house dust mites on flaky tail, Nc/Nga and Ox-
induced AD mice, and that the acidification of SC could be a novel intervention method 
to block the progress of the atopic march.
                                                                                                                                       
Key words: atopic march, acid, respiratory allergy, atopic dermatitis, flaky tail mice, 
Nc/Nga mice, oxazolone, Dermatofagoides pteronyssinus
1Acidification of stratum corneum prevents atopic march 
in murine models
Hae-Jin Lee
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Eung Ho Choi)
I. Part 1. Topical acidic cream prevents the development 
of atopic dermatitis- and asthma-like lesions in murine 
model
1. Abstract
Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is 
the initial step of the atopic march that eventually progresses to respiratory allergies. 
Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for 
normal skin barrier function. To determine whether an oxazolone (Ox)-induced AD 
murine model can develop airway inflammation by topical application and nasal 
inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 
2‘atopic march animal model’, and whether an acidic SC environment, made by repeated 
application of acidic cream, can interrupt this atopic march. During repeated treatment 
with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and 
neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle 
were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced 
AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. 
Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-
like skin lesions. These results indicate that a novel atopic march animal model can be 
developed by repeated topical and nasal treatments with house dust mite on Ox-induced 
AD mice, and that the acidification of SC could be a novel intervention method to block 
the atopic march.
32. Introduction
Atopic dermatitis (AD) is a common, chronic inflammatory skin disease characterized 
by pruritus, eczematous skin lesions, immunodysregulation, epidermal barrier 
dysfunction, and IgE-mediated sensitization to food and environmental allergens. The 
striking increase in the incidence of AD observed in recent decades has been attributed to 
the resettlement of populations from rural to urban areas, where a lack of early exposure 
to a variety of microbes purportedly results in reduced immune tolerance.(1, 2) In general, 
the clinical manifestations of AD predate the development of asthma and allergic rhinitis, 
suggesting that AD is an ‘entry point’ for subsequent atopic diseases, in a process called 
the ‘atopic march’.(3, 4)
Many studies suggest that the development of asthma in individuals with AD is 
secondary to easy allergen sensitization through a primarily defective epidermal barrier, 
which enables allergens(e.g. house dust mites) to easily penetrate the skin and then make 
contact with antigen-presenting cells, Langerhans cells (LCs), in the skin(5-7). After LCs 
capture and process the penetrated allergens, they migrate to draining lymph nodes and 
interact with naïve T cells and then promote Th2 inflammation leading to systemic 
allergy(8). In addition, the impaired skin barrier can be further aggravated by chronic 
colonization by Staphylococcus aureus which secretes superantigens(9). Superantigens in 
AD skin stimulate keratinocytes to produce thymic stromal lymphopoietin(TSLP) which
induces polyclonal activation of T cells, which results in exaggerated Th2 inflammatory 
responses leading to AD aggravation and promotion of systemic Th2 responses including 
respiratory allergies. 
Thus, prevention of the atopic march is a great challenge for many physicians. 
Maintenance of acidic pH in the stratum corneum (SC) is an important factor for normal 
4skin barrier function. Elias et al. hypothesized that a reduced level of filaggrin and, in 
particular, its acidic derivative, urocanic acid, increases SC pH and alters the activity of 
multiple serine proteases and two ceramide-generating enzymes that regulate the 
homeostasis of the SC.(2) The acidic pH of the SC, which is regulated by secretory 
phospholipase A2 and the sodium/hydrogen antiporter-1, regulates several main 
protective functions of the skin including permeability barrier homeostasis, SC integrity 
and cohesion, and antimicrobial defense, as well as primary cytokine activation.(10) 
Prolonged SC neutralization provokes profound abnormalities in SC function, due to pH-
induced high SP activity.(11) In addition, Fluhr et al(12) revealed that the delay in 
acidification of neonatal SC results in abnormalities in permeability barrier homeostasis 
and SC integrity and are likely due to pH-induced modulations in enzyme activity in 
animal model. Simple acidification of the SC substantially prevented AD development by 
repairing the barrier impairment followed by immune abnormalities in oxazolone (Ox)-
treated hairless mice.(13) Based on this information, we assumed that long-standing or 
repeated barrier damage followed by or occurring in AD is the initial step of the atopic 
march that eventually progresses to airway allergies. Furthermore, we predicted that 
maintenance of SC acidity could be used as an interventional modality to block the atopic 
march. Therefore, our first hypothesis was that an Ox-induced AD murine model could 
develop airway inflammation after repeated topical and nasal application of house dust 
mites, and that this model could be used as a novel ‘atopic march animal model.’ Our 
second hypothesis was that an acidic environment around the SC, created by repeated 
treatment with an acidic cream, could interrupt this atopic march.
This Ox-induced AD murine model recapitulates virtually all clinical, structural, lipid 
biochemical, and immunological features of human AD, including: (i) chronic, pruritic, 
5inflammatory dermatosis, (ii) elevated transepidermal water loss (TEWL) level; (iii) 
ultrastructural and lipid biochemical abnormalities typical of AD; (iv) tissue eosinophilia, 
elevated serum IgE level, and Th2-dominant immunophenotype; (v) decreased expression 
of two key antimicrobial peptides (AMPs), cathelicidin-related antimicrobial peptide 
(CRAMP) and mBD3; and (vi) decreased expression of epidermal differentiation markers 
including filaggrin, loricrin, and involucrin.(13-15) Therefore, we established an animal 
model of the atopic march by modifying this Ox-induced AD mouse model, and assessed 
the therapeutic and preventative effects of SC acidification in blocking the atopic march.
63. Materials and methods
Animals and Materials 
All animal procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of Yonsei University Wonju Campus. Thirty-six female hairless 
mice (6 weeks old) were purchased from OrientBio (Seongnam, Korea). Mice were kept 
under controlled humidity (40%) and temperature (22±2oC) conditions. 4-
Ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone) and acetone were purchased 
from Sigma-Aldrich (St Louis, MO, USA). Extracted antigen of Dermatofagoides 
pteronyssinus, a house dust mite, was purchased from the Department of Environmental 
Medical Biology, Yonsei University (Seoul, Korea). All laboratory measurements were 
performed under blinded conditions or by blinded researchers. The acidic cream was 
composed of citric acid purchased from Sigma-Aldrich and vehicle (Cetaphil® cream ; 
Galderma, Lausanne, Switzerland), adjusted with a pH meter. Neutralization of the acidic 
cream was performed with NaOH.
Development of an atopic march model by topical application and nasal inhalation 
of Dp in Ox-induced AD mice
A hapten-induced AD murine model (Ox-AD) with multiple similar features of human 
AD was developed as done in previous studies.(13-15) One group (Ox-plus-Dp group, 
n=6) was sensitized by a single topical treatment of 60 μl of 5% Ox and challenged by 
repeated application of 0.01% Ox, while the other two groups, including a non-treated 
control group (n=6) and a Dp-only-treated control group (application and inhalation of 
only Dp, n=6), were not treated with Ox. After the fifth Ox challenge, 40 mg of 0.5% 
mite (Dp) antigen (Ag) mixed with petrolatum was also applied to the skin of the Dp-only 
7control group and the Ox-plus-Dp group twice a week for a total of 10 times. During the 
last 3 days of the experiments, 100 μg of Dp Ag was intra-nasally inhaled daily (Fig. 1a). 
After a total of 53 days of repeated Ox challenges and Dp applications, the gross 
appearance, the skin barrier functions such as basal transepidermal water loss (TEWL) 
and the SC hydration, and the degree of allergic inflammation in skin, blood, and 
respiratory system were evaluated in all mice.
Intervention of the atopic march model with an acidic cream
For the acidic cream group, 200 mg of acidic cream (pH 2.8, vehicle cream adjusted 
with citric acid) was applied topically twice a day on the dorsal skin for 46 days after 
sensitization and of Ox. During the course of Ox challenge, cream was applied after 
application of Ox. For non-treated control groups, no Ox or interventional cream was 
applied. For the vehicle group, plain Cetaphil® cream (pH 5.5) was applied as previously 
performed.(16) For the neutralized cream group, neutralized cream was applied topically 
twice a day (Fig. 1b). 
Basal TEWL was measured with a Tewameter TM210 (Courage and Khazaka, Cologne, 
Germany), and SC hydration was assessed as capacitance with a Corneometer CM820 
(Courage and Khazaka) just before each application of Ox and at 24 h after the last 
application of Ox and Dp, as described previously.(17) Twenty-four hours after the last 
treatment, specimens of skin, blood, and lung were collected to evaluate the degree of 
allergic inflammation, which was measured by mRNA and protein expression.
8Figure 1. Methods for development of an atopic march model by topical application 
and nasal inhalation of a house dust mite (Dermatofagoides pteronyssinus; Dp) to 
oxazolone (Ox)-induced AD mice (a) and interruption of the atopic march model 
with acidic cream (b).
9Tissue preparation, immunohistochemistry, and immunofluorescence
Immunohistochemical stains were performed to assess epidermal differentiation. Briefly, 
5-μm-thick paraffin sections were incubated with the primary antibodies of differentiation 
marker proteins of keratinocytes, including filaggrin, involucrin, loricrin, PAR-2, and 
TSLP (Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. After three 
cycles of washes, sections were incubated with the secondary antibody for 30 min. 
Staining was detected with an ABC-peroxidase kit (Vector Labs, Burlingame, CA, USA), 
and sections were then counterstained with hematoxylin. To quantify the density of 
immunohistochemical stain, three pictures from each section were taken at 100x 
magnification and labeled. An investigator without any information on the specimens 
ranked the pictures in order of the intensity of immunostaining (highest intensity received 
first rank). The Mann-Whitney test was used for statistics. Representative pictures from 
each group were chosen for publication.
ELISA for serum IgE and TSLP
The serum levels of IgE and TSLP were determined using a mouse IgE ELISA kit 
(Koma Biotech, Seoul, Korea) and a mouse TSLP ELISA kit (R&D Systems, 
Minneapolis, MN, USA). To detect serum IgE levels, whole blood samples were 
centrifuged at 5,000 rpm for 5 min at room temperature. The sample serum and standard 
solution were added to the plates pre-coated with antibodies specific to IgE and TSLP and 
incubated for 1 hour at room temperature. Then, mouse IgE and TSLP detection 
antibodies conjugated to horseradish peroxidase were added to each well and incubated 
for 1 hour at room temperature. Next, a color development with TMB substrate was 
added to each well for 20 min. Sulfuric acid solution was then added to each well to stop 
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the reaction. The enzyme-substrate reaction was measured using a microtiter plate reader 
(BioTek Instruments, Inc., Winooski, VT, USA) to read the plate at 450 nm ± 2 nm 
wavelength. After triplicate measurements, the sample concentrations of IgE and TSLP 
were compared to the O.D. of the samples relative to the standard curve.
Bronchoalveolar lavage (BAL)
After each mouse was anesthetized, the trachea was cannulated and the lung was 
lavaged with 1 mL of Hank’s balanced salt solution via the intubation tube.(18) 
Bronchoalveolar lavage fluid (BALF) was obtained by two rounds of aspiration. Total 
numbers of cells were counted and cell smear preparations were made. Cells were stained 
with Wright–Giemsa stain and eosinophils, lymphocytes, macrophages, and neutrophils 
were counted and expressed as a percentage of 400 total cells. The counts of eosinophils, 
lymphocytes, macrophages, and neutrophils in the BALF were determined by multiplying 
their percentages in total cells.
Total RNA preparation and cDNA synthesis with blood and lung tissue
Total RNA preparation and cDNA synthesis were performed using the same methods as 
our previous report.(14, 16) Total RNA was extracted using a monophasic solution of 
phenol and guanidine isothiocyanate (TRIzol Reagent; Invitrogen, Carlsbad, CA, USA). 
RNA concentration was determined by a UV-visible spectrophotometer (Amersham 
Biosciences, Piscataway, NJ, USA) at 260 nm. Aliquots (1.0 ug) of RNA from each 
sample were reverse transcribed using Moloney murine leukemia virus reverse 
transcriptase (MML-V RTase, Promega, Madison, WI, USA). Reverse transcription was 
performed by adding 1X RT-buffer, 2 mM deoxynucleotide triphosphates (dNTPs, 
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Promega), 0.2 pM oligo dT primer (16mer) (Bioneer Inc., Daejeon, Korea), and MML-V 
RTase (2.5 units/ul) in 20 ul reaction volumes. Samples were then incubated at 42℃ for 
45 min before storage at -20℃.
Quantitative PCR analysis of gene expression 
Expression of specific mRNAs was quantified using a Rotor-Gene™ 3000 (Corbett Life 
Science, Brisbane, Australia), as in our previous report.(14, 16, 19) Briefly, 10 ul PCR 
reactions were set up containing: Quantitect SYBR green PCR kit Master mix (Qiagen, 
Hilden, Germany) in a 2X solution, 8 mM manganese chloride, 200 uM deoxynucleotide 
triphosphates (dNTPs), 1.25 units Hotstart Taq polymerase, and 0.5 pM/uL each of probes 
and primers. About 60 ng of cDNA was used per reaction. Primers for PAR-2 and TSLP 
were designed based on GeneBank sequences using Primer 3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi/, Massachusetts Institute of 
Technology, Cambridge, MA, USA).
All reactions used GAPDH as a housekeeping gene. Data were obtained as Ct values 
(the cycle number at which logarithmic PCR plots cross a calculated threshold line) 
according to the manufacturer's guidelines and were used to determine the ΔCt values (Ct 
of target gene−Ct of housekeeping gene) as raw data for gene expression. Fold changes 
in gene expression were determined by subtracting ΔCt values for Ox with Dp samples 
and acidic cream-treated samples from their respective control samples. The resulting 
ΔΔCt values were then used to calculate fold change in gene expression as 2-ΔΔCt. All 
reactions were performed in triplicate and the results are expressed as the mean of values 
from three separate experiments. Samples were amplified under the following conditions: 
95℃ for 15 minutes followed by 45 cycles of 95℃ for 15 seconds and 60℃ for 1 
12
minute.
Statistical analysis 
All data are expressed as mean ± SE. Statistical analyses were performed using One 
Way ANOVA or Mann-Whitney test for assaying the density of immunohistochemical 
staining.
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4. Results
Repeated Ox challenge combined with topical application and nasal inhalation of 
Dp provokes AD-like skin lesions with elevated serum TSLP and IgE levels
In our study, repeated Ox challenge induced AD-like skin lesions, as described in 
previous reports.(13-15) The Ox-plus-Dp group showed remarkable erythema, edema, 
lichenification, and scales compared with controls (Fig. 2a). Post-treatment basal TEWL 
increased and SC hydration decreased significantly in the Ox-plus-Dp group (Figs. 2b 
and c). Post-treatment serum IgE and TSLP also increased significantly in the Ox-plus-
Dp group (Figs. 2d and e). In addition, we evaluated sequential levels of serum TSLP in 
our model. After the 5th challenge of Ox, serum TSLP significantly increased and was 
then maintained until the last challenge of the experiments (Fig. 2f). The expression of 
TSLP and PAR-2, as measured by immunohistochemical stain, increased gradually 
according to the number of repeats of Ox challenge (Fig. 2g). Eosinophils in the skin also 
significantly increased in the Ox-plus-Dp group compared with controls (Fig. 3a). The 
expression levels of epidermal differentiation markers such as filaggrin, involucrin, and 
loricrin were significantly decreased in the Ox-plus-Dp group after the 23rd challenge of 
Ox combined topical treatment and nasal inhalation of Dp (Fig. 3b). 
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Figure 2. Gross appearance of AD was prominent in the Ox-plus-Dp group (a), 
which had increased basal TEWL (b), SC hydration (c), serum IgE (d), and TSLP 
expression (e) compared to controls. According to sequential challenges with Ox, TSLP 
expression was elevated in the serum and skin (f), while PAR-2 expression was increased 
in the skin, by immunohistochemical staining (g). *P<0.05, compared to non-treated 
control, Ox sensitization and Ox 3rd challenge. Control (Dp only), topical application and 
nasal inhalation of Dp without Ox treatment; Ox-plus-Dp, repeated Ox challenge 
combined with topical application and nasal inhalation of Dp.
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Repeated Ox challenge combined with topical application and nasal inhalation of Dp 
produces a novel atopic march model by provoking asthma-like lesions, including 
airway eosinophilia and increased expression of PAR-2 and TSLP in lung tissue
Airway eosinophilia is a hallmark of asthma.(20) BAL was performed after the 23rd 
challenge of Ox combined topical treatment and nasal inhalation of Dp. Post-treatment 
BAL showed a significant increase in total cell count in the Ox-plus-Dp group (Fig. 3c), 
in which eosinophils as well as macrophages and neutrophils were significantly increased 
compared with the controls (Fig. 3d). The mRNA of PAR-2 and TSLP in the lung tissue 
significantly increased in the Ox-plus-Dp group compared with the controls (Figs. 3e and 
f). The expression levels of PAR-2 and TSLP were also increased in the Ox-plus-Dp 
group compared to the controls, as revealed by immunohistochemical staining (Fig. 3g). 
These results indicated that this murine model shows ‘atopic march’ from AD to 
respiratory allergy.
16
Figure 3. AD-like skin lesions provoked by repeated Ox challenge combined with 
topical application and nasal inhalation of Dp showed significant increased tissue 
eosinophils (a) and reduced epidermal differentiation, as presented by filaggrin, 
involucrin, and loricrin expression levels (b). Total cell count (c) and individual cell 
count (d) of the BAL were increased in the Ox-plus-Dp group. mRNA (e and f) and tissue 
expression (g) of PAR-2 and TSLP were also prominent in the Ox-plus-Dp group. Control 
(Dp only), topical application and nasal inhalation of Dp without Ox treatment; Ox-plus-
Dp, repeated Ox challenge combined with topical application and nasal inhalation of Dp. 
*P<0.05, compared to control; +P<0.05, compared to Ox plus Dp.
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Topical applications of acidic cream prevent the occurrence of AD-like skin lesions 
and the progression to asthma-like lung lesions 
We next assessed the effect of the acidic SC environment made by an acidic cream on 
the process of an initial appearance of AD-like skin lesions followed by asthma-like lung 
lesions, which was defined as atopic march. Topical application of acidic cream 
significantly improved gross AD lesions (Fig. 4a), significantly decreased basal TEWL, 
and significantly increased SC hydration compared to other treatments such as vehicle or 
neutralized cream (Figs. 4b and c). Skin treated with only acidic cream in the absence of 
Ox treatment showed no changes in gross appearance or skin barrier functions (data not 
shown). Post-treatment BAL of the acidic cream group showed a significant decrease in 
total cell count, and numbers of eosinophils, as well as macrophages and neutrophils, 
increased significantly compared to the controls (Figs. 4d and e). The mRNA levels of 
PAR-2 and TSLP in the lung tissue significantly decreased in the Ox-plus-Dp group after 
acidic cream application compared to other treatments such as vehicle or neutralized 
cream (Figs. 4f and g). 
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Figure 4. Topical acidic cream prevents the occurrence of AD-like skin lesions and 
prevents the progression to asthma-like lung lesions provoked by repeated Ox 
challenge combined with topical application and nasal inhalation of Dp. The acidic 
cream group showed better gross appearance (a), basal TEWL (b), and SC hydration (c) 
compared with vehicle or neutralized cream groups. Bronchoalveolar lavage (d and e) 
performed after the 23rd Ox challenge and topical application and nasal inhalation of Dp. 
The mRNA levels of PAR-2 (f) and TSLP (g) in the lung tissue were measured after the 
23rd Ox challenge combined with topical application and nasal inhalation of Dp. Vehicle 
cream, vehicle-treated group; neutralized cream, pH 7.4 neutralized citric acid cream-
treated group; acidic cream, pH 2.8 citric acid cream-treated group. +P<0.05, compared 
to vehicle cream and neutralized cream group.
19
5. Discussion
The concept of the atopic march was hypothesized to describe the progression of atopic 
diseases from AD in infants to asthma or allergic rhinitis in children.(4, 7) Kubo et al.(1) 
suggested a theoretical model of barrier disruption followed by percutaneous sensitization, 
which may apply to the pathogenesis of the atopic march. After abrogation of the SC 
barrier, protease-active allergens and uncontrolled intrinsic proteases may activate PAR-2 
and Toll-like receptors on keratinocytes.(21). Keratinocytes then produce 
proinflammatory cytokines such as TNF-α, IL-1, and TSLP. During SC perturbation, 
dendrites of activated LCs penetrate the weakened tight junctions of upper stratum 
granulosum and then take up exogenous antigens.(22) Such percutaneous sensitization 
and repeated allergen challenges via different routes such as lung, nasal cavity, or 
intestinal tract, are speculated to manifest as the atopic march. Many researchers have 
attempted to establish an animal model of atopic march. There have been several studies 
done using an occlusive patch of ovalbumin (OVA) to make an atopic march model.(23-
26) Although asthma-like lung lesions were developed using these methods, AD-like skin 
lesions including eczematous lesions and disrupted SC barrier were not fully developed. 
Although IL-13 transgenic mice with OVA treatment (27), RBP-jCKO mice with OVA 
(28), and Ox challenge with OVA (29) expressed AD-like skin lesions combined with 
asthma-like lung lesions, intra-peritoneal injection of OVA was applied for sensitization, 
not epicutaneous sensitization via damaged skin barrier. 
Oxazolone (Ox) are commonly used to provoke allergic contact dermatitis and have 
been thought to evoke a Th1-dominated response as a hapten.(15) It has been reported, 
however, that multiple challenges of an extended period with Ox to the skin of hairless 
mice cause the skin inflammation to shift from Th1-dominated delayed type 
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hypersensitivity response to a chronic Th2-dominated inflammatory response similar to 
human AD.(13, 14, 30, 31) Skin barrier abnormality was associated with increased TEWL 
and impaired lamellar body secretion, decreased SC ceramide contents and hydration, 
resulting in reduced lamellar membranes, as observed in AD patients. Furthermore, as in 
human AD, epidermal serine protease activity in SC increased and the expression of two 
lamellar body-derived antimicrobial peptides, CRAMP and mBD3, declined after 
multiple Ox challenges, paralleling the decrease of their human homologues in AD skin 
lesions.(13, 15, 31) Even if the repeated sensitization model of hapten is not a genetically 
driven model, it may be applicable to extrinsic allergen driven, acquired form of AD.
In order to produce asthma-like lung lesions, we applied Dp antigens, which is one of 
potent allergens to produce respiratory allergies in human, topically to AD-like skin 
lesions with disrupted barrier and then caused nasal inhalation of Dp, which revealed a 
natural mechanism of allergen penetration, systemic circulation, and allergen challenge 
via different routes such as lung or nasal cavity (Fig. 2).(1) In addition, topical application 
of Dp antigen combined with Ox challenges created more severe eczematous lesions 
compared with Ox treatment only (data not shown). Our study indicated that repeated 
treatment with Ox, a hapten, disrupts the skin barrier, which contributes to the 
development of AD-like skin lesions by promoting the epicutaneous penetration of 
allergens such as house dust mites and then leads to the development of asthma-like lung 
lesions. Indeed, topical application and nasal inhalation of Dp without barrier disruption 
did not produce any inflammatory lesions in the skin or lung (Figs. 3 and 4). This finding 
indicates that active allergen uptake by LCs did not occur when the skin barrier was intact 
and did not lead to an increase in cytokines and TSLP.
TSLP in the pathogenesis of human AD has been well documented to be highly 
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increased in the lesional skin as well as in the blood of AD patients.(1, 32) Moreover, 
TSLP was significantly higher in acute AD than in chronic AD (27). Since the Ox-AD 
murine model was introduced (15), several studies have used this model to elucidate the 
pathogenesis and treatment of AD-related diseases.(13, 14, 29-31, 33) In the current study, 
we confirmed that blood TSLP level was increased from the fifth challenge of Ox, which 
induced early eczema appearance, and was maintained until the last Ox challenge that 
resulted in severe eczema (Fig. 2f). The elevated TSLP may sufficiently activate LCs. In 
addition, the expression of PAR-2 and TSLP in murine skin was also increased after Ox 
challenge (Fig. 2g). Therefore, we showed the additional evidence that Ox-treated 
hairless mice can be a useful animal model of AD.
Keratinocyte differentiation is also incomplete in AD lesions.(34) In our atopic march 
model, the expression levels of filaggrin as well as those of involucrin and loricrin 
decreased after repeated Ox challenges. These decreases compromise the integrity of the 
skin barrier and then provoke transcutaneous penetration of exogenous allergens, such as 
Dp (Fig. 3b). This disruption in the skin barrier may also induce asthma-like lung lesions 
more easily. The expression of the filaggrin gene is down-regulated in AD skin by Th2 
cytokines such as IL-4 and IL-13.(35) Therefore, we believe that repeated Ox challenges 
can alter filaggrin expression by inducing Th2 allergic inflammation.
Expression of PAR2 has been demonstrated in various cells of the skin and the lung. 
Many studies indicated that the activation of PAR2 by endogenous or exogenous agonists 
such as allergens contributes to the pathogenesis of AD or asthma which is manifested by 
airway inflammation and hyper-responsiveness.(36-39) TSLP also takes part in the 
pathogenesis of atopic diseases including AD and asthma. Kouzaki et al(40) reported that 
TSLP was induced in airway epithelial cells by exposure to allergen-derived proteases, 
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and that PAR-2 was involved in this process. Repeated Ox challenge and Dp application 
increased the expression of PAR-2 and TSLP in the blood and lung tissue used in our 
study (Fig. 3). From our results, we assume that Dp-induced asthma can be easily 
produced when the skin barrier is disrupted by repeated Ox challenges, which induced 
systemic PAR-2 and TSLP as well as eosinophils, although Dp application alone was not 
sufficient to induce asthma. Increased systemic PAR-2 and TSLP may help to induce 
asthma-like lung lesions more easily. 
The various preventative implications of AD were introduced. Lee et al(41) revealed 
that in vivo treatment with poly-γ-glutamic acid at early time points can prevent the 
development of AD in NC mice, which may have therapeutic applications for human AD. 
Recent study showed that deficiency of n-6 polyunsaturated fatty acids is mainly 
responsible for AD-like pruritic skin inflammation, which might give us a clue that early 
administrations of n-6 polyunsaturated fatty acids may prevent pruritic skin inflammation 
in AD.(42) Kim et al(43) showed consecutive low concentration of formaldehyde 
exposure in NC/Nga mice might be a key factor to exacerbate house dust mite-mediated 
AD-like skin inflammation.
The pH of the SC influences at least four key epidermal functions including 
permeability barrier homeostasis, integrity/cohesion (desquamation), initiation of 
inflammation, and antimicrobial defense.(44) Therefore, the maintenance of low acidity 
provides a mechanism that integrates these key functions.(13) Based on this background, 
Hatano et al(13) suggested that an acidic environment could prevent AD-like skin lesions 
in an Ox-induced murine model. We also observed similar results of preventive and/or 
therapeutic effects of topical acidic cream in the Ox-AD murine model (Fig. 4). Moreover, 
total cell count including eosinophils in the BALF and the expression levels of PAR-2 and 
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TSLP in the lung tissue decreased significantly in an acidic SC environment made by 
acidic cream, which revealed the blocking of progression to asthma-like lesions.
Based on our results, we assume that prolonged skin barrier damage induced by 
repeated Ox challenge provoked the elevation of SC pH. Elevated SC pH increased the 
expression of PAR-2 and TSLP in the blood and the skin, which contributed to AD-like 
lesions with elevated IgE and Th2 cytokines. Application of Dp antigen to the AD-like 
lesions and nasal cavity also induced the respiratory allergy, which was represented by 
airway eosinophilia and elevated PAR-2 and TSLP levels in the lung tissue. Acidification 
of SC environment with acidic cream could interrupt this cycle early, thus preventing the 
atopic march (Fig. 5). In summary, our results show that an atopic march murine model 
can be developed by Dp application to the Ox-AD mouse model. The acidic SC 
environment made by application of acidic cream could prevent the progression of atopic 
march from AD to respiratory allergies, which implies that acidification of the SC could 
be a novel intervention method to prevent the atopic march.
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Figure 5. Possible explanation for the development of our atopic march model and 
intervention
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II. Part 2. Atopic march from atopic dermatitis to 
asthma-like lesions in NC/Nga mice is accelerated or 
aggravated by neutralization of stratum corneum but 
partially inhibited by acidification
1. Abstract
Prolonged and/or repeated damage to the skin barrier followed by atopic dermatitis 
(AD) is an initial step in atopic march that ultimately progresses to respiratory allergy. 
Maintaining normal SC acidity has been suggested as a therapeutic or preventive strategy 
for barrier impairment caused by skin inflammation. We determined whether a 
representative AD murine model, NC/Nga mice, develops airway inflammation after 
repeated epicutaneous application followed by inhalation of house dust mite (HDM), 
implying atopic march, and whether prolongation of non-proper SC acidity accelerates 
respiratory allergy. HDM was applied to the skin of NC/Nga mice, accompanied by the 
application of neutral cream (pH 7.4) or acidic cream (pH 2.8) for 6 weeks. Intranasal 
inhalation of HDM was administered daily during the last 3 days. Repeated epicutaneous 
applications followed by inhalation of HDM in NC/Nga mice induced an atopic march-
like progression from AD lesions to respiratory allergy. Concurrent neutral cream 
treatment aggravated the allergic inflammation in the skin and respiratory system, 
whereas an acidic cream partially alleviated these symptoms. Collectively, we developed 
an atopic march in NC/Nga mice by HDM application, and found that prevention of a 
neutral environment in the SC may be an interventional method to inhibit the march.
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2. Introduction
Atopic dermatitis (AD), which is one of the most common chronic inflammatory 
dermatosis, is characterized by an impaired epidermal barrier, dry skin, pruritus, 
eczematous lesions, abnormal immune response, and IgE-mediated allergy to various 
exogenous antigens (Lee and Lee, 2014). The clinical symptoms of AD generally precede 
the development of asthma and allergic rhinitis. This finding suggests that AD could be a 
doorway to the successive events of allergic diseases, the so called ‘atopic march’ 
(Gordon, 2011; Spergel and Paller, 2003). Researchers have suggested that the occurrence 
of asthma in AD patients could result from enhanced sensitization of allergens through a 
defective skin barrier, enabling allergens to penetrate the skin easily, and  subsequently 
to come in contact with to contact with epidermal Langerhans cells (LCs), antigen 
presenting cells (Callard and Harper, 2007; Zheng et al., 2011). After capturing and 
processing the penetrated exogenous allergens, LCs move to regional lymph nodes and 
present the allergens to naïve T cells, which leads to systemic allergy by encouraging Th2 
inflammation  (Allakhverdi et al., 2007). Besides, thymic stromal lymphopoietin (TSLP) 
secreted by the keratinocytes of disrupted epidermis activates polyclonal T cells. These T 
cells, in turn, induce excessive Th2 inflammatory responses, which could aggravate the 
AD and trigger the systemic Th2 responses including respiratory allergies (Laouini et al., 
2003). 
The acidity (pH) of the stratum corneum (SC) affects the epidermal key functions 
including permeability barrier homeostasis, SC integrity and cohesion, initiation of 
inflammation, processing of the secreted lamellar body (LB) lipids, and antimicrobial 
defenses (Hachem et al., 2010, Elias et al., 2015). The skin surface of AD lesions exhibits 
an increased pH, which causes bacterial growth and results in allergic inflammation and 
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worsening of AD. In a hapten-induced animal model of AD, simple acidification of SC 
significantly blocks the progression of barrier impairment and the downstream immune 
abnormalities (Hatano et al., 2009). These studies give us a clue to possible novel 
modalities that might prevent progression of the atopic march (Lee et al., 2014). 
Acidic microdomain was observed within the extracellular matrix of the SC by two-
photon fluorescence lifetime imaging (FLIM). The mean pH of the SC increased with 
depth due to an increase in the ratio of neutral to acidic regions within the SC. FLIM 
definitely showed that the existence of aqueous acidic pockets within the lipid-rich 
extracellular matrix leads to the acid mantle of the SC (Hanson et al., 2002). It also 
revealed that SC acidification occurs through the progressive accumulation of acidic 
microdomains (Behne et al., 2002). These results give us a clue that surface pH directly 
reflects changes in the extracellular matrix of the SC as an acidic pH microdomain in the 
SC. The abnormal acidification demonstrated by FLIM is related to decreased Na+/H+ 
antiporter (NHE1) expression in the epidermis of moderately aged mice. Diminished 
NHE1 levels cause the elevation of SC pH, which contributes to suboptimal activation of 
β-glucocerebrosidase, leading to defective maturation of lipid processing and lamellar 
membranes in turn. These abnormalities were normalized by exogenous acidification of 
the SC (Choi et al., 2007). 
The NC/Nga mouse has a mutation on chromosome 9, which is related to the increased 
IgE production and a Th2 dominant inflammation. The skin lesions arise spontaneously 
or secondarily to exposure of various aeroallergens, which are similar to AD in humans. 
The mice also present abnormalities of skin barrier functions, such as increased basal 
transepidermal water loss (TEWL) and abnormal SC hydration under conventional 
conditions, and diminished ceramide metabolism (Aioi et al., 2001). In addition, exposure 
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to a standard environment alone is not enough to reveal AD-like symptoms in these mice; 
however, epicutaneous stimulation with certain environmental allergens (e.g., house dust 
mite allergens) provokes AD-like symptoms (Kim et al., 2014). 
Based on previous reports, we first hypothesized that NC/Nga mice, as a murine model 
of inherited AD, would establish respiratory inflammation after epicutaneous treatment 
followed by subsequent inhalation of house dust mite (HDM), similar to the model of the 
atopic march. Second, we hypothesized that the atopic march could be interrupted by 
maintaining SC acidity or accelerated by neutralization of the SC.
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3. Materials and methods
Animals and Materials 
All animal procedures were approved by the Yonsei University Wonju Campus 
Institutional Animal Care and Use Committee (IACUC). Twenty-four female NC/Nga 
mice (5 weeks old) were purchased from SLC Japan (Shizuoka, Japan). Mice were kept 
under conditions of controlled humidity (40%) and temperature (22 ± 2°C). Extracted 
antigen of Dermatofagoides pteronyssinus (Dp), a HDM, was purchased from the 
Department of Environmental Medical Biology, Yonsei University (Seoul, Korea). All 
laboratory measurements were performed under blinded conditions. An acidic cream (pH 
2.8) was made by the addition of citric acid (Sigma-Aldrich; St Louis, MO, USA) to 
vehicle cream. A neutral cream (pH 7.4) was made by neutralization of the acidic cream 
with sodium hydroxide (NaOH). The vehicle was plain Cetaphil® cream with a pH of 5.5 
(Galderma, Lausanne, Switzerland), as previously described (Jung et al., 2011).
Development of an atopic march model in NC/Nga mice by epicutaneous application 
and subsequent nasal inhalation of Dp, application of acidic or neutral cream, and 
measurement of skin barrier function including surface pH
Five-week-old NC/Nga mice and BALB/c mice (as a control) were used in this study. 
Once a week the mice were anesthetized and the hair on their dorsal skin was shaved. Dp 
antigen (Ag) was mixed with petrolatum to make a 0.5% ointment. Four percent sodium 
lauryl sulfate (SLS) and 0.5% Dp Ag were applied to the dorsal skin of the NC/Nga mice 
(NC/Nga + Dp) and the control mice (BALB/c + Dp) twice a week for 6 weeks (a total of 
12 applications). During the last 3 days of the experiment, 100 μg of Dp Ag was given 
daily by intranasal inhalation (Lee et al., 2014). While Dp Ag was being applied 
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epicutaneously, 200 mg of acidic cream (pH 2.8) was applied twice a day on the same 
skin sites for 45 days (acidic cream group). For the non-treated control groups (BALB/c), 
no cream was applied. For the neutral cream group, neutralized cream (pH 7.4) was 
applied twice a day (Fig. 6). After a total of 46 days of epicutaneous and intranasal 
application with Dp Ag, the gross appearance and barrier functions of the skin, including 
basal TEWL and SC hydration, skin surface pH, and the degree of allergic inflammation 
of the skin, blood, and respiratory system were evaluated in all mice. Surface pH was 
measured with pH meter (WTW, Weilheim, Germany). The Basal TEWL was measured 
with the Tewameter TM210 (Courage and Khazaka, Cologne, Germany), and SC 
hydration was assessed as capacitance with the Corneometer CM820 (Courage and 
Khazaka) 24 h after the final application of Dp, that is 12 h after the final application of 
cream, as described previously (Choi et al., 2005; Lee et al., 2014). Twenty-four hours 
after the last treatment of Dp, specimens of skin, blood, and lung were collected to 
evaluate the degree of allergic inflammation as measured by mRNA and protein 
expression. In addition, in order to evaluate the maintenance time of lowered or elevated 
pH by application of acidic or neutral cream, skin surface pH was measured at pre-
treatment and 0 h, 1 h, 3 h, 6 h, 9 h and 12 h right after the application of acidic (pH 2.8) 
or neutral (pH 7.4) creams as well as vehicle (pH 5.5) cream. (each group, n=4)
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Figure 6. Establishment of a model of atopic march in NC/Nga mice by epicutaneous 
application and subsequent nasal inhalation of HDM, and the intervention by 
topical acidic or neutral cream.
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Evaluation of macroscopic AD-like skin lesions
Scoring of dermatitis was assessed macroscopically in a blinded fashion using the 
following scoring procedure. The development of (i) erythema, (ii) edema, (iii) 
excoriation, (iv) scale, and (v) lichenification was each scored as 0 (none), 1 (mild), 2 
(moderate), and 3 (severe). The total symptom severity score was defined as the sum of 
the individual scores.
Tissue preparation, immunohistochemistry, and immunofluorescence
Immunohistochemical staining was performed to assess epidermal differentiation and 
inflammation. Briefly, 5-μm thick paraffin sections were incubated with primary 
antibodies against epidermal differentiation marker proteins such as filaggrin, involucrin, 
and loricrin, protease-activated receptor-2 (PAR-2), and thymic stromal lymphopoietin 
(TSLP) (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. 
After three cycles of washing, the sections were incubated with the appropriate secondary 
antibody for 30 min. Staining was detected with the ABC-peroxidase kit (Vector Lab, 
Burlingame, CA, USA) and counterstaining with hematoxylin was performed. To 
quantify the density of immunohistochemical staining, three pictures from each section 
were taken at 100x magnification and labeled. An investigator without any information 
on the specimen ranked the pictures in order of the intensity of immunostaining (the 
highest intensity received the first rank). Representative images of each group are 
provided.
Enzyme-linked immunoassay (ELISA) for serum IgE and TSLP
Serum levels of IgE and TSLP were determined using ELISA kits for mouse IgE (Koma 
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Biotech, Seoul, Korea) and mouse TSLP (R&D systems, Minneapolis, MN, USA). To 
detect serum IgE levels, whole blood samples were centrifuged at 5,000 rpm for 5 min at 
room temperature (RT). The sample serum and standard solutions were added to plates 
that were pre-coated with specific antibodies for IgE and TSLP, and incubated for 1 h at 
RT. Horseradish peroxidase-conjugated mouse secondary detection antibodies were added 
to each well and incubated for 1 hour at RT. TMB substrate was added to each well and 
incubated for 20 min for color development. A sulfuric acid solution was added to each 
well to stop the reaction and the enzyme-substrate reaction was measured using a 
microtiter plate reader (BioTek Instruments, Inc., Winooski, VT, USA) at a wavelength of 
450 ± 2 nm. After triplicate measurements, the concentrations of IgE and TSLP in the 
samples were determined by comparison with a standard curve.
Bronchoalveolar lavage (BAL)
BAL was performed as previously described.(Lee et al., 2014) After each mouse was 
anesthetized, the trachea was cannulated and the lung was lavaged with 1 mL of Hank’s 
balanced salt solution via the intubation tube. Bronchoalveolar lavage fluid (BALF) was 
obtained by two rounds of aspiration. Total numbers of cells were counted and cell smear 
preparations were made. Cells were stained with Wright–Giemsa stain and eosinophils, 
lymphocytes, macrophages, and neutrophils were counted and expressed as a percentage 
of 400 total cells. The counts of eosinophils, lymphocytes, macrophages, and neutrophils 
in the BALF were determined by multiplying their percentages in total cells.
Total RNA preparation and cDNA synthesis with blood and lung tissue, and 
Quantitative PCR analysis of gene expression 
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Total RNA preparation and cDNA synthesis were performed as previously described 
(Jung et al., 2011; Lee et al., 2012). Expression of specific mRNAs was quantified using a 
Rotor-Gene™ 3000 (Corbett Life Science, Brisbane, Australia), as in our previous reports 
(Hong et al., 2010; Jung et al., 2011; Lee et al., 2012). Briefly, 10-μl PCR reactions were 
set up containing Quantitect SYBR green PCR kit Master mix (Qiagen, Hilden, 
Germany) in a 2X solution, 8 mM manganese chloride, 200 μM deoxynucleotide 
triphosphates (dNTPs), 1.25 units Hotstart Taq polymerase, and 0.5 pM/μl each of probes 
and primers. Approximately 60 ng of cDNA was used per reaction. Primers for PAR-2 
and TSLP were designed based on GeneBank sequences using Primer 3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi/, Massachusetts Institute of 
Technology, Cambridge, MA). All reactions included GAPDH as a housekeeping gene. 
Data were obtained as Ct values (the cycle number at which logarithmic PCR plots cross 
a calculated threshold line) according to the manufacturer's guidelines and were used to 
determine ΔCt values (Ct of target gene−Ct of housekeeping gene) as raw data for gene 
expression. Changes in gene expression were determined by subtracting ΔCt values for 
samples and acidic cream-treated samples from their respective control samples. The 
resulting ΔΔCt values were used to calculate fold change in gene expression as 2-ΔΔCt. 
All reactions were performed in triplicate, and the results are expressed as the mean of 
values from three separate experiments. Samples were amplified under the following 
conditions: 95°C for 15 minutes, followed by 45 cycles of 95°C for 15 seconds and 60°C 
for 1 minute.
Statistical analysis 
All data were expressed as mean ± SEM. ANOVA or Kruskal-Wallis test were 
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performed when three or more groups were compared or to compare the density of 
immunohistochemical staining. For individual comparison, Student’s unpaired t-test was 
used in case of normal distribution, and Mann-Whitney test was used in case of non-
normal distribution or ranking variables. *p<0.05 was regarded as statistically significant. 
Statistical analysis was conducted using SPSS software 10.1 (SPSS, Chicago, IL).
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4. Results
Repeated epicutaneous application of HDM extract provokes remarkable AD-like 
skin lesions and barrier dysfunction in NC/Nga mice, a representative murine model 
of inherited AD, which are aggravated by a neutral cream. 
Repeated epicutaneous application of a HDM, Dermatofagoides pteronyssinus (Dp) 
antigen provoked remarkable AD-like skin lesions with a high eczema score in the 
NC/Nga mice but not in the control mice (BALB/c mice). BALB/c mice did not exhibit 
eczema lesions despite epicutaneous treatment of SLS and Dp antigen. Treatment with 
SLS alone to NC/Nga mice also induced eczema lesions. Moreover, application of a 
neutral cream with Dp extract (NC/Nga SLS + Dp + pH 7.4 cream) resulted in more 
prominent eczema lesions compared to other NC/Nga treatment groups. Time course of 
skin surface pH after the application of creams on the skin of NC/Nga mice revealed that 
skin surface pH is maintained by acidic or neutral cream for approximately 6 hours after 
application of the creams (Fig. 7a). Application of an acidic cream (NC/Nga SLS + Dp + 
pH 2.8) alleviated eczema lesions in Dp-treated NC/Nga mice, but this effect was not 
significant (Fig. 7b). Post-treatment basal TEWL was increased and SC hydration was 
significantly decreased in the group treated with neutral cream (NC/Nga SLS + Dp + pH 
7.4 group; Fig. 7c and d). However, there was no significant difference in skin surface pH 
among all groups, measured 24 h after the final application of Dp, that is 12 h after the 
final application of cream (Fig. 7e). 
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Figure 7. Repeated epicutaneous application of HDM (Dp) extract followed by nasal 
inhalation provokes remarkable AD-like lesions and barrier disruption in NC/Nga 
mice. Symptoms were aggravated by neutral cream, but neither aggravated nor improved 
by acidic cream. Systemic allergic inflammation was aggravated by neutral cream but 
partially improved by acidic cream. (a) Time course of skin surface pH after application 
of acidic or neutral cream (n=4, each group). (b) Eczema scores and gross appearance, (c) 
basal TEWL, (d) SC hydration, (e) skin surface pH, (f) serum IgE, and (g) TSLP after Dp 
treatment were compared among treatment groups. ANOVA showed p<0.05 in all 
measurements except (e) surface pH. Results are mean ± SEM. *p＜0.05, compared to 
control (BALB/c SLS+Dp); +p<0.05, compared to NC/Nga SLS+Dp.
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Systemic and cutaneous allergic inflammation and abnormal epidermal 
differentiation induced in NC/Nga mice are aggravated by neutral cream but 
partially improved by acidic cream. 
After treatment, serum total IgE levels significantly increased in all of the NC/Nga 
mice compared to control BALB/c mice. Among NC/Nga mice, mice that were treated 
with neutral cream showed the most prominent increase in serum IgE. In contrast, acidic 
cream did not decrease serum IgE in NC/Nga mice treated with SLS and Dp antigen (Fig. 
7f). Post-treatment serum TSLP was significantly increased in the NC/Nga SLS+Dp 
group. Mice treated with neutral cream (NC/Nga SLS + Dp + pH 7.4) showed an increase 
in serum TSLP similar to that of the NC/Nga SLS + Dp group. Application of acidic 
cream significantly decreased serum TSLP in the NC/Nga SLS + Dp group (Fig. 7g).
Also, the number of tissue eosinophils was noticeably increased in the skin of NC/Nga 
SLS + Dp + pH 7.4 group (Fig. 8a). Semiquantitative analysis of the expression of 
epidermal differentiation markers (filaggrin, involucrin, and loricrin) by 
immunohistochemical staining showed that their expression was significantly decreased 
in the NC/Nga SLS + Dp group compared to the control BALB/c SLS + Dp group (Fig. 
8b). Application of neutral cream to the NC/Nga SLS + Dp group significantly decreased 
expression of these markers, whereas acidic cream significantly increased their 
expression. Semiquantitative analysis demonstrated that epidermal expression of protease 
activated receptor - 2 (PAR-2) and TSLP significantly increased in the NC/Nga SLS + Dp 
group compared to the control BALB/c SLS + Dp group (Fig. 8b). Application of neutral 
cream to the NC/Nga SLS + Dp group significantly increased expression of PAR-2 and 
TSLP, whereas acidic cream significantly decreased their expression. 
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Figure 8. Cutaneous allergic inflammation and abnormal epidermal differentiation 
induced in NC/Nga mice are aggravated by neutral cream but partially improved by 
acidic cream. (a) Tissue eosinophils were counted with H&E staining, and (b) expression 
of epidermal differentiation markers (filaggrin, involucrin, loricrin), PAR-2, and TSLP 
were measured by immunohistochemical staining in skin specimens taken after repeated 
epicutaneous treatment and nasal inhalation of Dp. (a) ANOVA and (b) Kruskal-Wallis 
test showed p<0.05 in all measurements. Results are mean ± SEM. *p<0.05, compared to 
control (BALB/c SLS + Dp); +p<0.05, compared to NC/Nga SLS + Dp. (n=6, each 
group)
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Repeated epicutaneous application followed by nasal inhalation of HDM extract 
produces asthma-like airway inflammation and AD-like skin lesions in NC/Nga mice, 
implying atopic march; these symptoms are aggravated by neutral cream and 
partially improved by acidic cream. 
Because airway eosinophilia is a characteristic manifestation of asthma (Tian et al., 
2011), we performed bronchoalveolar lavage (BAL) after 3 consecutive days of nasal 
inhalation of Dp. After treatment, the total cell count of the BAL was significantly 
increased in the NC/Nga SLS + Dp group; this increase was aggravated by treatment with 
neutral cream (NC/Nga SLS + Dp + pH 7.4 group) and decreased by application of the 
acidic cream with statistical significance (Fig. 9a). The number of eosinophils, 
macrophages, and neutrophils were significantly increased in the NC/Nga SLS + Dp 
group, similar to the results of total cell count (Fig. 9b). Quantitation of mRNA and 
immunohistochemical staining revealed increased expression of PAR-2 and TSLP in the 
lung tissue of the NC/Nga SLS + Dp group, which was further aggravated by application 
of neutral cream application and decreased by acidic cream with statistical significance 
(Fig. 9c, d and e).
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Figure 9. Repeated epicutaneous application of HDM (Dp) extract followed by nasal 
inhalation produces asthma-like inflammatory response as well as AD lesions in 
NC/Nga mice, implying atopic march. Symptoms are aggravated by neutral cream, but 
partially improved by acidic cream. BAL, RQ-PCR for mRNA expression, and 
immunohistochemical staining of PAR-2 and TSLP were performed in the lung tissue 
after Dp treatment. (a) Total cells and (b) individual cell count in the BAL, and (c, d) 
mRNA and (e) expression of PAR-2 and TSLP  in the lung tissue were measured. (a-d) 
ANOVA and (e) Kruskal-Wallis test showed p<0.05 in all measurements. Results are 
mean ± SEM.  *p<0.05, compared to control (BALB/c SLS + Dp); +p<0.05, compared 
to NC/Nga SLS + Dp and NC/Nga SLS + Dp + pH 2.8. (n=6, each group)
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5. Discussion
Since Strid et al. suggested the idea of a skin barrier defect initiating allergic 
sensitization and showed its mechanism in mice (Strid et al., 2006), the theoretical model 
described by Kubo et al. (Kubo et al., 2012) has been considered applicable to the atopic 
march pathogenesis. Break down of the epidermal barrier activates the intrinsic proteases 
and permits the penetration of protease-active allergens, which could activate Toll-like 
receptors and PAR-2 on keratinocytes (Briot et al., 2009). The keratinocytes subsequently 
produce proinflammatory cytokines including IL-1, TNF-α, and TSLP. Along with the 
disruption of SC, the activated LCs extend their dendrites through the weakened tight 
junctions and attach to the penetrating allergens (Kubo et al., 2009). Such percutaneous 
sensitization of exogenous allergens, followed by repeated challenges from various routes, 
including lung, nasal cavities, and gastrointestinal tract, is thought to develop the atopic 
march. In our study, only epicutaneous treatment and nasal inhalation of HDM with no 
disruption of permeability barrier in the control group of Balb/c mice did not demonstrate 
such remarkable inflammatory lesions in the skin, as well as the lung (Figs. 7-9). This 
result suggests that the uptake of active allergens and the activation of LCs did not take 
place when the epidermal barrier was not disrupted, therefore there was no increase in the 
levels of cytokines and TSLP. It is well known that the expression of TSLP is highly 
increased in lesional skin and the blood of patients with AD, and that this elevation in 
TSLP expression is sufficient to activate LCs during AD development (Kubo et al., 2012; 
Liu, 2006). 
There have been many attempts to develop animal models of atopic march. Although 
all of the results present asthma-like lung lesions as well as AD-like skin lesions, 
intraperitoneal injections of ovalbumin were used for sensitization rather than 
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epicutaneous application via a disrupted barrier (Li, 2014). To develop asthma-like lung 
lesions, HDM antigen was treated to AD lesions presenting a broken barrier before the 
nasal inhalation in NC/Nga mice, a murine model of inherited AD. This provided a more 
natural and physiologic mechanism for allergen sensitization compared to previous
sensitization methods. Recently, we reported that a murine model of acquired AD induced 
by repeated hapten (oxazolone) application progresses to asthma-like lesions under more 
natural and physiologic mechanisms (Lee et al., 2014).
The NC/Nga mouse shows an abnormal skin permeability barrier, which presents 
increased TEWL and abnormal skin hydration. These are combined with Th2 
inflammatory responses and impaired ceramide metabolism even in normal condition 
(Matsuda et al., 1997). Our results show that the eczema score was increased in the group 
of NC/Nga mice treated with SLS only, which confirms that NC/Nga mice have inherited 
abnormalities in skin barrier functions. Their AD-like skin changes are suggested to be 
independent of IgE and Th2 reaction, as the skin lesions developed in STAT6-deficient 
NC/Nga mice with undetectable IgE serum levels (Yagi et al., 2002). Although the Th2 
response may not be necessary for AD development in NC/Nga mice, additional 
applications of SLS and HDM may cause earlier barrier disruption and allergen exposure, 
which could contribute to the Th2 immune response. Therefore, in our study a greater 
increase in eczema scores was associated with poorer barrier functions and a greater 
increase in serum TSLP and IgE. 
In AD lesions, filaggrin expression is downregulated by Th2 cytokines such as IL-4, 
IL-13, IL-22, and IL-25 regardless of FLG gene mutations and the decrease in NMF is 
dependent on the severity of lesional inflammation, rather than the FLG mutation (Jung et 
al., 2014; Novak, 2012). In addition, epidermal differentiation in AD lesions is 
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incomplete (Elias, 2010). In this atopic march-like model using NC/Nga mice, the 
expression of filaggrin, involucrin and loricrin decreased after multiple epicutaneous 
applications of HDM antigens. Repeated application of HDM antigen to the NC/Nga 
mouse model aggravated AD skin lesions and then severely decreased filaggrin 
expression, which could disrupt the skin barrier and eventually permit skin permeation of 
exogenous antigens including HDM (Fig. 8b). This process may also result in the asthma-
like lesions. 
PAR-2 and TSLP expression has been demonstrated in various tissues in addition to 
skin and lung, which are also involved in the occurrence of AD and respiratory allergy 
(Ebeling et al., 2005; Gu and Lee, 2012; Lee et al., 2014). TSLP expression is induced in 
airway epithelial cells following exposure to allergen-derived proteases, and PAR-2 plays 
a role in this process (Kouzaki et al., 2009). In our study, repeated HDM application to 
damaged skin increase the levels of TSLP, IgE, or PAR-2 in the systemic circulation or 
lung tissue (Fig. 9). Based on our results, we presume that HDM-induced asthma could 
occur more easily when the skin barrier is more severely impaired and AD lesions are 
more severe. These conditions provoke an increase in systemic TSLP and IgE as well as 
eosinophils, whereas HDM application alone does not easily induce asthma. Systemic 
TSLP levels may affect the PAR-2 and TSLP in distant epithelial organs such as the lung, 
which might be readily affected by the HDM allergen. 
There are controversies as to whether filaggrin deficiency per se increases the SC pH 
or not (Ohman et al., 1998; Fluhr et al., 2010; Vávrová et al., 2014). However, decrease in 
filaggrin degradation products in AD lesions might contribute to an increase in the SC pH 
high enough to induce serine proteases (SP) activation in the SC which optimally acts 
under neutral to alkaline pH (Brattsand et al., 2005). An elevated SC pH also increases 
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the activity of SP such as kallikrein 5 (KLK5) and KLK7 (stratum corneum chymotryptic 
enzyme), resulting in overdegradation of corneodesmosomes (CD) and decrease of SC 
integrity and cohesion (Lee et al., 2010). On the other hand, the elevation of SC pH 
decreases the activity of lipid-processing enzymes, which are indispensable for the 
production of free fatty acids and ceramide in the SC, and thus impairs lipid processing 
and eventually disrupts the permeability barrier of epidermis (Hachem et al., 2010; 
Hatano et al., 2009). 
Several reports present some indirect evidence that acidification of SC prevents the 
penetration of the SC by external allergens including HDM. This evidence was 
demonstrated with ultrastructural changes of SC and SG shown by fine EM pictures 
(Hachem et al., 2003, 2005, 2010; Hatano et al., 2009). Therefore, we believe that 
allergens from Dp extract with high molecular weight over 18,000 dalton (Lind, 1985) 
only limitedly penetrate the skin barrier which is partially improved by SC acidification 
in NC/Nga mice. Hatano et al. reported that an acidic environment can inhibit the 
formation of AD-like skin lesions in the hapten-induced AD model (Hatano et al., 2009). 
We previously reported that acidification of SC inhibits the development of both asthma-
like lesions and AD-like lesions by HDM in the murine model (Lee et al., 2014). In the 
present study using NC/Nga mice, we observed an aggravating or harmful effect of 
neutral cream and a partial preventive effect of acidic cream on the atopic march. A 
previous study already confirmed that acidic treatment (pH 2.0 with 2M HCl) to HDM 
(Dp) preserved the allergenicity and antigenicity of Dp. No significant differences were 
observed in the antigenic profile of native and acid treated extracts (Fernández-Caldas et 
al., 2008). The difference in the degree of response might reflect differences in skin 
structure between these mouse models. Compared to hairless mice, NC/Nga mice with 
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abundant terminal hairs have a thinner SC and weaker skin barrier function. Also, the 
transient receptor potential vanilloid type 1(TRPV1) channel, which is activated by 
diverse noxious stimuli including capsaicin, low pH or heat, is deeply associated with 
permeability barrier function. Blockade of its activation accelerates barrier recovery and 
alleviates AD-like symptoms in NC/Nga mice and Ox-AD mice (Yun et al., 2011). 
Therefore, we assume that the acidic cream might more easily activate TRPV1 in the 
epidermis of NC/Nga mice with relatively thinner SC compared to hairless mice. Another 
considerable factor is that AD-like skin changes in NC/Nga mice are IgE/Th2-
independent, which is different with AD lesions of hairless mice and humans (Yagi et al., 
2002). This immunologic difference might be the cause of the partial or minimal pH-
dependent preventative effects in the NC/Nga mice, and might also explain the lack of 
statistical difference in surface skin pH among the groups. In addition, skin surface pH 
was maintained approximately for 6 hours after application of the creams, but the creams 
were applied every 12 hours (Fig. 7a). Further study is needed to evaluate whether the 
acidic cream is more effective if applied every 6 hours.
In summary, we demonstrate that a murine model of atopic march can be developed by 
application of HDM in NC/Nga mice. Maintenance of a neutral skin environment 
aggravates barrier function and AD lesions which in turn, eventually, accelerates the 
atopic march. Therefore, prevention of a neutral environment on the SC may be an 
intervention to inhibit the progression of AD to respiratory allergies, an atopic march.
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III. Part 3. Maintenance of Stratum Corneum Acidity 
Interrupts Atopic March in Flaky Tail Mice with 
Congenital Skin Barrier Defect due to Inherited Filaggrin 
Deficiency
1. Abstract
Congenitally impaired skin barrier followed by atopic dermatitis (AD) is an initial step 
in atopic march that eventually progresses to respiratory allergy. Maintenance of an acidic 
pH in the stratum corneum (SC) is an important factor for normal epidermal barrier 
function. We determined whether an AD murine model, flaky tail(Flgft) mice with 
congenital barrier defect due to filaggrin deficiency, can develop airway inflammation by 
repeated topical application followed by nasal inhalation of a house dust mite(HDM), 
(defined as a novel ‘atopic march-like animal model’), and whether maintenance of an 
acidic SC environment by continuous application of acidic cream can interrupt this atopic 
march. During the course of HDM treatment to the Flgft mice, acidic cream (pH 2.8) or 
neutral cream(pH7.4) adjusted by citric acid or sodium hydroxide mixed with vehicle 
were applied twice daily. Repeated applications and inhalations of HDM to AD murine 
model induced AD skin lesions followed by respiratory allergies, defining it as an atopic 
march model. Maintenance of SC acidity inhibited the occurrence of respiratory allergic 
inflammation as well as AD-like skin lesions. These results indicate that a novel atopic 
march models can be developed by repeated application of HDM on Flgft mice, and that 
the acidification of SC could be a novel intervention method to block the progress of the 
atopic march.
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2. Introduction
Atopic dermatitis(AD) is one of the most frequent chronic inflammatory skin diseases 
characterized by epidermal barrier dysfunction, xerosis, eczematous lesions, pruritus, 
immunodysregulation, and IgE-mediated sensitization to exogenous allergens.(1) The 
obvious increase in the incidence of AD observed in recent decades has been due to the 
resettlement of populations from rural to urban areas, where a lack of early exposure to a 
variety of microbes results in reduced immune tolerance.(2, 3) The clinical manifestations 
of AD predate the development of asthma and allergic rhinitis in a process called the 
‘atopic march’, suggesting that AD is an ‘entry point’ for subsequent allergic disease.(4, 
5) The concept of the atopic march was hypothesized to describe the progression of 
atopic disorders from AD in infants to asthma and allergic rhinitis in children.
It has been reported that the development of asthma in the individuals with AD is 
secondary to easy allergen sensitization through a primarily defective epidermal barrier, 
which enables allergens(e.g. house dust mites (HDM)) to easily penetrate the skin and 
then make contact with antigen-presenting cells, Langerhans cells(LCs), in the skin(6-9). 
LCs, then, capture and process the penetrated allergens, migrate to draining lymph nodes 
and interact with naïve T cells, which promote Th2 inflammation leading to systemic 
allergy(10). Meanwhile, thymic stromal lymphopoietin (TSLP) secreted by the 
keratinocytes of disrupted epidermis activates polyclonal T cells. These T cells, in turn, 
induce excessive Th2 inflammatory responses, which could aggravate the AD and trigger 
the systemic Th2 responses including respiratory allergies.(11)
Many physicians, therefore, have attemted to prevent of the atopic march. The acidic pH 
of SC is a key factor for many protective functions including permeability barrier 
homeostasis, SC integrity and cohesion, antimicrobial defense, because it is important for 
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the functional activity of enzymes involved in processing of the SC lipids, and 
modulating the activity of the serine protease required for coordinated epidermal 
differentiation and cornified cell envelope formation.(12, 13) In AD, there is an increase 
of pH in lesional skin resulting in bacterial growth, allergic inflammation and aggravation 
of AD.(14) In a hapten-induced and immune-dysregulated(NC/Nga) animal model of AD, 
simple acidification of SC significantly blocks the progression of barrier impairment and 
the downstream immune abnormalities(9, 15, 16). This study gives us the clue and 
possibility of novel AD treatment in that maintenance of a normal or hyperacidic pH 
could reverse or prevent AD in human. However, haten-induced atopic march model only 
represents acquired AD without hereditary abnormalities and NC/Nga mice have IgE/Th2 
independent pathogenesis which may not fully represent immune status of atopic
march.(9, 16)
Filaggrin(FLG) mutation is a significant predisposition to an increased risk of 
developing atopic diseases including AD, atopic asthma, allergic rhinitis, and nickel and 
food allergies, although filaggrin is not found in bronchial epithelium.(17) In general, AD 
associated with FLG mutations is earlier onset, more ‘atopic’ and likely to be associated 
with asthma as well as more severe and persistent manifestations.(18) If FLG mutation is 
occurred, the FLG–associated SC barrier is disrupted; decreased formation and secretion 
of lamellar body(LB), cornified envelope, and corneodesmosome, elevated skin surface  
pH and decreased tight junction proteins, which leads to increased episodes of 
percutaneous allergen exposure.(2, 19) Flaky tail(Flgft) mouse, which showing the 
deficiency of filaggrin and natural moisturizing factors(NMF), has been used to 
investigate the role of filaggrin in AD. The spontaneous flaky tail(ft) mouse arose on the 
background of an existing recessive hair phenotype, matted(ma). It also presents 
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spontaneous dermatitis with increased IgE levels, endogenous protease (KLKs 5, 7, and 
14) activity, TSLP expression, and basophil in the skin, which shows many similarities of 
AD phenotype.(20, 21)
For that reasons, we believed that the flaky tail mouse could be the most proper animal 
model similar to human AD patient with congenital barrier defect due to inherited 
deficiency of filaggrin. Therefore, we developed an atopic march murine model using 
flaky tail mouse. Secondly, we elucidated that this atopic march was interrupted by 
maintenance of the SC acidity and accelerated by neutralization of the SC.
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3. Materials and methods
Mice and materials 
All animal procedures were approved by the Yonsei University Wonju Campus 
Institutional Animal Care and Use Committee (IACUC). C57BL/6J (B6) female mice 
were purchased from OrientBio (Sungnam, Korea). Flgft (STOCK a/a ma ft/ma ft/J) mice, 
which carry double-homozygous flaky tail (ft) and matted (ma) mutations, were 
outcrossed onto B6 at Kyoto university (Kyoto, Japan).(48) Mice were kept under 
controlled humidity (40%) and temperature (22±2oC) conditions. Extracted antigen of 
Dermatofagoides pteronyssinus, a house dust mite, was purchased from the Department 
of Environmental Medical Biology, Yonsei University (Seoul, Korea). All laboratory 
measurements were performed under blinded conditions or by blinded researchers. The 
acidic cream was composed of citric acid purchased from Sigma-Aldrich (St Louis, MO, 
USA) and vehicle (Cetaphil®; Lausanne, Switzerland), adjusted with a pH meter. 
Neutralization of the acidic cream was performed with NaOH.
Development of an atopic march model by topical application and nasal inhalation 
of Dermatofagoides pteronyssinus(Dp) in Flgft mice and intervention of the atopic 
march model with an acidic cream
Five-week-old Flgft mice and B6 mice were used in this study. Once a week the mice 
were anesthetized and the hair on their dorsal skin was shaved. Dp antigen (Ag) was 
mixed with petrolatum to make a 0.5% ointment. Forty mg of 0.5% mite (Dp) Ag mixed 
with petrolatum was applied on the skin of the control group(B6 + Dp, n=6) and the Flgft
with Dp groups(n=6, each) twice a week for a total of 20 times. During the last 3 days of 
the experiment, 100 μg of Dp Ag was given daily by intranasal inhalation.(9) While 
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appling Dp on the Flgft mice, 200 mg of acidic cream (pH 2.8, vehicle cream adjusted 
with citric acid) was applied topically twice a day on the dorsal skin for 45 days (acidic 
cream group). For non-treated control groups(B6, n=6), no interventional cream was 
applied. For the neutralized cream group(pH 7.4, vehicle cream adjusted with sodium
hydroxide, n=6), neutralized citric acid cream was topically applied twice a day (Fig. 10). 
The vehicle was plain Cetaphil® cream with pH 5.5 (Galderma, Lausanne, Switzerland) 
as previously performed.(9, 16, 37) After a total of 70 days of Dp application, gross 
appearance, skin barrier functions such as basal transepidermal water loss (TEWL), SC 
hydration and skin surface pH, and the degree of allergic inflammation in the skin, blood, 
and respiratory system were evaluated in all mice. Surface pH was measured with pH 
meter (WTW, Weilheim, Germany). Basal TEWL was measured with the Tewameter 
TM210 (Courage and Khazaka, Cologne, Germany), and SC hydration was assessed as 
capacitance with the Corneometer CM820 (Courage and Khazaka) at 24 h after the final 
application of Dp, as described previously.(49) Twenty-four hours after the last treatment, 
specimens of skin, blood, and lung were collected to evaluate the changes in allergic 
inflammation as measured by mRNA and protein expression. 
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Figure 10. Development of an atopic march model in Flgft mice by epicutaneous 
application and subsequent nasal inhalation of house dust mite (Dp) and the 
application of acidic or neutral cream.
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Evaluation of macroscopic AD-like skin lesions
Scoring of dermatitis was assessed macroscopically in a blinded fashion using the 
following scoring procedure described by Saunders et al.(29) and adapted from 
assessment of skin inflammation in the NC/Nga mouse model.(50) The development of 
(i) erythema, (ii) edema, (iii) excoriation, (iv) scale, and (v) lichenification was each 
scored as 0 (none), 1 (mild), 2 (moderate), and 3 (severe). The total score for each mouse 
was calculated from the sum of individual scores for each parameter.
Tissue preparation and immunohistochemistry
Immunohistochemical staining was performed to assess epidermal differentiation and 
inflammation. Briefly, 5-μm thick paraffin sections were incubated with primary 
antibodies against epidermal differentiation marker proteins such as filaggrin, involucrin, 
and loricrin, protease-activated receptor-2 (PAR-2), and thymic stromal lymphopoietin 
(TSLP) (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. 
After three cycles of washing, the sections were incubated with the appropriate secondary 
antibody for 30 min. Staining was detected with the ABC-peroxidase kit (Vector Lab, 
Burlingame, CA, USA) and counterstaining with hematoxylin was performed. To 
quantify the density of immunohistochemical staining, three pictures from each section 
were taken at 100x magnification and labeled. An investigator without any information 
on the specimen ranked the pictures in order of the intensity of immunostaining (the 
highest intensity received the first rank). Representative images of each group are 
provided.
ELISA for serum IgE and TSLP
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Serum levels of IgE and TSLP were determined using ELISA kits for mouse IgE (Koma 
Biotech, Seoul, Korea) and mouse TSLP (R&D systems, Minneapolis, MN, USA) as 
previously reported.(9, 16) To detect serum IgE and TSLP levels, whole blood samples 
were centrifuged at 5,000 rpm for 5 min at room temperature (RT). The sample serum and 
standard solutions were added to plates that were pre-coated with specific antibodies for 
IgE and TSLP, and incubated for 1 h at RT. Horseradish peroxidase-conjugated mouse 
secondary detection antibodies were added to each well and incubated for 1 hour at RT. 
TMB substrate was added to each well and incubated for 20 min for color development. A 
sulfuric acid solution was added to each well to stop the reaction and the enzyme-
substrate reaction was measured using a microtiter plate reader (BioTek Instruments, Inc., 
Winooski, VT, USA) at a wavelength of 450 ± 2 nm. After triplicate measurements, the 
concentrations of IgE and TSLP in the samples were determined by comparison with a 
standard curve.
Bronchoalveolar lavage (BAL)
BAL was performed as previously described.(9, 16) After each mouse was anesthetized, 
the trachea was cannulated and the lung was lavaged with 1 mL of Hank’s balanced salt 
solution via the intubation tube. Bronchoalveolar lavage fluid (BALF) was obtained by 
two rounds of aspiration. Total numbers of cells were counted and cell smear preparations 
were made. Cells were stained with Wright–Giemsa stain and eosinophils, lymphocytes, 
macrophages, and neutrophils were counted and expressed as a percentage of 400 total 
cells. The counts of eosinophils, lymphocytes, macrophages, and neutrophils in the BALF 
were determined by multiplying their percentages in total cells.
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Total RNA preparation and cDNA synthesis with blood and lung tissue and 
Quantitative PCR analysis of gene expression
Total RNA preparation and cDNA synthesis were performed as previously described.(37, 
51) Expression of specific mRNAs was quantified using a Rotor-Gene™ 3000 (Corbett 
Life Science, Brisbane, Australia), as in our previous reports (37, 51, 52). Briefly, 10-ul 
PCR reactions were set up containing Quantitect SYBR green PCR kit Master mix 
(Qiagen, Hilden, Germany) in a 2X solution, 8 mM manganese chloride, 200 μM 
deoxynucleotide triphosphates (dNTPs), 1.25 units Hotstart Taq polymerase, and 0.5 
pM/μl each of probes and primers. Approximately 60 ng of cDNA was used per reaction. 
Primers for PAR-2 and TSLP were designed based on GeneBank sequences using Primer 
3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi/, Massachusetts Institute 
of Technology, Cambridge, MA). All reactions included GAPDH as a housekeeping gene. 
Data were obtained as Ct values (the cycle number at which logarithmic PCR plots cross 
a calculated threshold line) according to the manufacturer's guidelines and were used to 
determine ΔCt values (Ct of target gene−Ct of housekeeping gene) as raw data for gene 
expression. Changes in gene expression were determined by subtracting ΔCt values for 
samples and acidic cream-treated samples from their respective control samples. The 
resulting ΔΔCt values were used to calculate fold change in gene expression as 2-ΔΔCt. 
All reactions were performed in triplicate, and the results are expressed as the mean of 
values from three separate experiments. Samples were amplified under the following 
conditions: 95°C for 15 minutes, followed by 45 cycles of 95°C for 15 seconds and 60°C 
for 1 minute.
Statistical analysis 
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All data were expressed as mean ± SEM. ANOVA or Kruskal-Wallis test were performed 
when three or more groups were compared or to compare the density of 
immunohistochemical staining. For individual comparison, Student’s unpaired t-test was 
used in case of normal distribution, and Mann-Whitney test was used in case of non-
normal distribution or ranking variables. *p<0.05 was regarded as statistically significant. 
Statistical analysis was conducted using SPSS software 10.1 (SPSS, Chicago, IL).
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4. Results
Repeated epicutaneous application of HDM extract provokes remarkable AD-like 
skin lesions and barrier dysfunction in Flgft mice, a representative murine model of 
inherited AD, which are prevented by acidic cream and aggravated by a neutral 
cream. 
Repeated epicutaneous application of a HDM, Dermatofagoides pteronyssinus (Dp) 
antigen provoked remarkable AD-like skin lesions with a high eczema score in Flgft mice. 
However the control mice (B6 mice) did not exhibit eczema lesions despite same 
epicutaneous treatment with Dp antigen. Moreover, application of a neutral cream with 
Dp extract (Flgft + Dp + pH 7.4) resulted in more prominent eczema lesions compared to 
other treatment groups. On the contrary, application of an acidic cream (Flgft + Dp + pH 
2.8) alleviated eczema lesions in Dp-treated Flgft mice significantly (Fig. 11a). Post-
treatment basal TEWL was increased and SC hydration was significantly decreased in the 
group treated with neutral cream(Flgft + Dp + pH 7.4 group) but significantly improved in 
the group with acidic cream(Flgft + Dp + pH 2.8 group)(Fig. 11b and c). Moreover, there 
was significant difference in skin surface pH among cream treated groups, which was 
measured 24 h after the final application of Dp, that is, 12 h after the final application of 
cream. Post-treatment SC pH decreased significantly in the group treated with acidic 
cream(Flgft + Dp + pH 2.8 group) and increased in the group with neutral cream(Flgft + 
Dp + pH 7.4 group) (Fig. 11d). 
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Figure 11. Repeated epicutaneous application of house dust mite (Dp) extract 
followed by nasal inhalation provokes remarkable AD-like skin lesions and barrier 
disruption in Flgft mice, a representative murine model of inherited AD. Those 
symptoms were improved by acidic cream but aggravated by neutral cream. Systemic 
allergic inflammation induced in Flgft mice was improved by acidic cream but aggravated 
by neutral cream. (a) Eczema scores and gross appearance, (b) basal TEWL, (c) SC 
hydration, (d) skin surface pH, serum IgE (e) and TSLP (f) after repeated epicutaneous 
application of house dust mite extract (Dp) followed by nasal inhalation were compared 
among treatment groups. ANOVA showed p<0.05 in all measurements. Results are mean 
± SEM. *p<0.05, compared to control (B6 + Dp and Flgft); +p＜0.05, compared to Flgft + 
Dp. (n=6, each group)
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Cutaneous and systemic allergic inflammation in Flgft mice were aggravated due to 
HDM and affected by SC acidity 
The number of tissue eosinophils in the skin was also significantly increased in the Flgft
+ Dp + pH 7.4 group and decreased in the Flgft + Dp + pH 2.8 goup compared to the Flgft
+ Dp  group(Fig. 12a). The expression of epidermal differentiation markers such as 
involucrin, and loricrin by immunohistochemical staining and semiquantitative analysis 
showed that their expression was significantly decreased in the Flgft + Dp group 
compared to the control B6 + Dp group(Fig. 12a). Application of neutral cream to the 
Flgft + Dp group significantly decreased expression of these markers, whereas acidic
cream significantly increased their expression except filaggrin. There was minimal 
expression of filaggrin among Flgft groups. Semiquantitative analysis of epidermal 
expression of PAR-2 and TSLP was significantly increased in the Flgft mice compared to 
control. Dp treatment increased their expression more. Application of neutral cream to the 
Flgft + Dp group significantly increased expression of PAR-2 and TSLP, whereas acidic 
cream significantly decreased their expression(Fig. 12b). 
Serum levels of total IgE and TSLP significantly increased in all of the Flgft mice with 
or without Dp treatment compared to control mice. Among Flgft mice, the mice that were 
treated with neutral cream showed the most prominent increase in serum IgE and TSLP. 
On the contrary, acidic cream significantly decreased serum IgE and TSLP in Flgft mice 
treated with Dp antigen (Fig. 12c and d). 
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Figure 12. Cutaneous allergic inflammation and abnormal epidermal differentiation 
induced in Flgft mice is aggravated by neutral cream but improved by acidic cream. 
Tissue eosinophils were counted with H&E staining (a) and expression of epidermal 
differentiation markers such as filaggrin, involucrin, and loricrin, PAR-2, and TSLP was 
measured by immunohistochemical staining (b) in skin specimens taken after repeated 
epicutaneous application and nasal inhalation of Dp. ANOVA (a) and Kruskal-Wallis test 
(b) showed p<0.05 in all measurements. Results are mean ± SEM. *p<0.05, compared to 
control (B6 + Dp); +p<0.05, compared to Flgft + Dp.
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Repeated epicutaneous application followed by nasal inhalation of HDM extract 
produces asthma-like airway inflammation as well as AD-like skin lesions in Flgft
mice, implying atopic march; it was interrupted by SC acidification, whereas 
aggravated by SC neutralization. 
Quantitation of mRNA and immunohistochemical staining revealed increased 
expression of PAR-2 and TSLP in the lung tissue of the Flgft + Dp group, which was 
further aggravated by application of neutral cream application and improved by acidic 
cream with statistical significance (Fig. 13a, b and c). Since airway eosinophilia is a 
hallmark of asthma (Tian et al., 2011), we performed BAL after 3 consecutive days of 
nasal inhalation of Dp. Total cell count of the BAL was significantly increased in the Flgft
mice with Dp application. This increase was significantly aggravated by treatment with 
neutral cream (Flgft + Dp + pH 7.4 group) and improved by application of the acidic 
cream(Fig. 13d). Each number of eosinophils, macrophages, and neutrophils was also 
significantly increased in the Flgft + Dp group, similar to the results of total cell count 
(Fig. 13e).
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Figure 13. Repeated epicutaneous application followed by nasal inhalation of a 
house dust mite extract (Dp) produces asthma-like airway inflammation as well as 
AD-like skin lesions in Flgft mice, implying atopic march. Those symptoms were 
improved by acidic cream but aggravated by neutral cream. Bronchoalveolar lavage 
(BAL), real-time RT-PCR for mRNA expression, and immunohistochemical staining for 
PAR-2 and TSLP in the lung tissue were performed after epicutaneous application and 
nasal inhalation of Dp. Total cell count (a) and individual cell count (b) of the BAL, and 
mRNA (c, d) and tissue expression (e) of PAR-2 and TSLP were measured after treatment. 
ANOVA (a-d) and Kruskal-Wallis test (e) showed p<0.05 in all measurements. Results 
are mean ± SEM. *p＜0.05, compared to control (B6 + Dp); +p＜0.05, compared to Flgft
+ Dp. (n=6, each group)
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5. Discussion
The concept of the atopic march was hypothesized to describe the progression of atopic 
disorders from AD in infants to asthma and allergic rhinitis in children(5, 8). Since Strid 
et al.(22) suggested the idea of epidermal barrier defect initiating allergic sensitization 
and showed its pathogenesis in murine model, the theoretical model described by Kubo et 
al. (2) has been considered applicable to the pathogenesis of atopic march. Abrogation of 
SC barrier promotes the penetration of protease-active allergens and uncontrolled 
intrinsic proteases, which may activate PAR-2 and Toll-like receptors on 
keratinocytes.(23). Keratinocytes then produce proinflammatory cytokines such as TNF-α, 
IL-1, and TSLP. Meanwhile, dendrites of activated LCs penetrate the weakened tight 
junctions of the upper stratum granulosum and take up exogenous antigens(24). Such 
percutaneous sensitization and chronic repeated allergen challenges via different routes, 
such as lung, nasal cavities, and intestinal tract, are speculated to manifest as the allergic 
march. In this study, along with our previous studies(9, 16), epicutaneous treatment and 
nasal inhalation of HDM with no disruption of SC barrier in the control mice without 
barrier defect did not provoke remarkable inflammatory lesions in the skin as well as the 
lung (Figs. 11-13). This result also suggests that the uptake of active allergens and the
activation of LCs did not take place when the epidermal barrier was not disrupted, 
therefore there was no increase in the levels of TSLP. It is well known that the expression 
of TSLP is highly increased in lesional skin and the blood of patients with AD, and that 
this elevation in TSLP expression is sufficient to activate LCs during AD development(2, 
25).
Since PAR-2 and TSLP expression has been reported in various tissues including skin and 
lung, they also take part in the occurrence of AD and respiratory allergy(9, 26, 27). TSLP 
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expression is induced when airway epithelial cells are exposed to allergen-derived 
proteases, and PAR-2 involves in this process(28). In our study, repeated HDM 
application to defected SC barrier increases the levels of TSLP, PAR-2, and IgE in the 
systemic circulation or lung tissue (Fig. 13). In addition, we could assume that HDM-
induced asthma could occur more easily when the skin barrier is more severely impaired 
and AD lesions are more severe. These conditions provoke an elevation of systemic TSLP 
and IgE as well as eosinophils, whereas HDM application alone on the impaired skin 
barrier rarely induce asthma. Systemic TSLP levels may affect the PAR-2 and TSLP in 
distant epithelial organs such as the lung, which might be readily affected by the HDM 
allergen.
Flgft mice, homozygous mutation of 5303delA in the FLG gene and Tmem79/Matt gene, 
have been used to investigate the role of filaggrin in AD(29). Topical application of HDM 
in Flgft mice induces skin lesions which are more clinically and histologically similar to 
those seen in AD with outside-to-inside skin barrier dysfunction(20). The relative 
contribution of Flg and ma to the compound phenotype has yet to be fully defined. 
Recently, Matted mouse gene is a predisposing gene for atopic dermatitis and a common 
SNP in MATT has an association with AD in human subjects(29). In addition, Sasaki et 
al(30) showed the Tmem79(ma/ma) mutation is responsible for the spontaneous 
dermatitis phenotype in matted mice, probably as a result of impaired LB secretory 
system and altered SC barrier function, which can also be found in Caucasians who have 
FLG mutations in dose dependant alterations(31). Thus far, Flgft mice might be one of the 
most represented animal model of AD corresponding with filaggrin mutation in human 
AD.
There are many studies which attempted to establish an animal model of the allergic 
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march. There have been several studies done using an occlusive patch of ovalbumin 
(OVA) to make an atopic march model. Although majority of these studies expressed 
atopic dermatitis-like skin lesions combined with asthma-like lung lesions, they used 
intraperitoneal injections for sensitization, not epicutaneous sensitization via damaged 
skin barrier. In addition, allergic reaction of OVA is disappeared in adulthood, whereas 
one of HDM still remains(32-35). Recently, we reported the murine models of acquired 
and inherited AD progresses to asthma-like lesions under more natural and physiologic 
mechanisms with favorable results(9, 16). In order to produce asthma-like lung lesions, 
we applied Dp antigens topically to skin lesions on the Flgft mice, a murine model of 
inherited AD, with disrupted barrier before nasal inhalation of Dp, which revealed more 
physiologic pathway of allergen penetration, systemic circulation, and allergen challenge 
via different routes, such as lung and nasal cavities(Fig. 10)(2). Recent study using 
filaggrin-deficient mice showed that innate immunity initiates dermatitis and the adaptive 
immunity required for subsequent development of compromised lung function.(36) Along 
with previous report, our results also showed similar results that there is no significant 
change on the lung without inhalation of HDM on Flgft mice(Fig. 13).
In AD skin, decreased SC hydration leads to a steeper water gradient across the SC as a 
result of filaggrin deficiency, thereby ‘driving’ increased TEWL(37). Filaggrin (FLG) 
mutations are a significant predisposition to an increased risk of developing atopic 
diseases including AD, atopic asthma, allergic rhinitis, and nickel and food allergies, 
although filaggrin is not found in bronchial epithelium(1, 8, 17). Besides, to promote the 
compaction of corneocytes, filaggrin monomers are degraded into natural moisturizing 
factors (NMFs) to maintain the hydration of the upper SC and to reduce the pH of the 
skin surfaces(3, 38, 39). If these proteins are decreased or absent due to FLG mutations, 
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the FLG–associated SC barrier is disrupted, which leads to increased episodes of 
percutaneous allergen exposure(2). Keratinocyte differentiation is also incomplete in AD 
lesions(38). In our allergic march model, the expressions of involucrin and loricrin were 
decreased after treatment of HDM, with minimal expression of filaggrin, which may 
imply disruption of the SC barrier and provocation of transcutaneous infiltration of 
allergens such as Dp (Fig. 12b). This may also induce asthma-like lesions easily.
Decrease in filaggrin degradation products in AD lesions might contribute to an increase 
in the SC pH high enough to induce activation of serine proteases(SP) in the SC which 
optimally acts under neutral to alkaline pH(40), although there are controversies whether 
filaggrin deficiency per se increases the SC pH or not (41-43). An elevated SC pH also 
increases the activity of SP such as kallikrein 5 (KLK5) and KLK7 (stratum corneum 
chymotryptic enzyme), resulting in overdegradation of corneodesmosomes (CD) and 
weakening of SC integrity and cohesion(44). On the other hand, the elevation of SC pH 
decreases the activity of lipid-processing enzymes, which are crucial for the production of 
free fatty acids and ceramide in the SC, and thus impairs lipid processing and eventually 
disrupts the permeability barrier of epidermis(12, 15). Based on our results, we assume 
that prolonged skin barrier damage induced by repeated HDM in Flgft mice provoked the 
elevation of SC pH. Elevated surface pH increased PAR-2 and TSLP in the blood as well 
as in the skin, which contributes to AD-like lesions with elevated IgE and Th2 cytokines. 
Application of Dp antigen on the AD-like lesions and respiratory system also induced 
respiratory allergies, represented by airway eosinophilia and elevated PAR-2 and TSLP in 
the lung tissue. Maintenance of an acidic skin environment would block this cycle early; 
hence, the allergic march could be prevented (Fig. 5).
Several indirect evidence of reports show that acidification of SC prevents the 
79
penetration of the SC by external allergens including HDM(9, 12, 15, 16, 45, 46). Hatano 
et al. reported that an acidic environment can inhibit the formation of AD-like skin 
lesions in the hapten-induced AD model(15). We previously reported that acidification of 
SC inhibits the development of both asthma-like lesions and AD-like lesions by HDM in 
the murine models(9, 16). In the present study using Flgft mice, we observed a preventive 
effect of acidic cream and an aggravating or harmful effect of neutral cream on the atopic 
march. A previous study already confirmed that acidic treatment to HDM (Dp) preserved 
the allergenicity and antigenicity of Dp with no significant differences in the antigenic 
profile of native and acid treated extracts(47). 
In summary, this animal study demonstrates that epicutaneous allergen sensitization 
through an inherited defective skin barrier can induce respiratory allergic inflammation. 
We demonstrate that a murine model of atopic march can be developed by application of 
Dp to Flgft mice. Our previous studies and present results indicate that application of Dp 
antigen to the AD-like lesions, regardless of acquired(hapten-induced) and 
inherited(defect of immune or SC barrier) etiology, and respiratory system readily 
induced respiratory allergies, as represented by airway eosinophilia and elevated PAR-2 
and TSLP expression in the lung tissue. Maintenance of a neutral skin environment 
aggravated and an acidic skin interrupted this cycle(Fig. 14). Therefore, maintenance of 
an acidic environment on the SC may be a novel method of intervention to block the 
progression of AD to respiratory allergies (the atopic march).
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Figure 14. Possible explanations for the development of atopic march models using 
flaky tail mouse and intervention.
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IV. Conclusion
In conclusion, these results indicate that novel atopic march models can be developed 
by repeated application of house dust mites on flaky tail, Nc/Nga and Ox-induced AD 
mice, and that the acidification of SC could be a novel intervention method to block the 
progress of the atopic march.
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Abstract in Korean (국문 요약)
아토피행진 동물모델에서 각질층의 산도유지에
의한 아토피행진의 진행예방
< 지도교수 최 응 호 >
연세대학교 대학원 의학과
이 해 진
각질층의 적당한 산도유지는 정상적인 피부장벽기능을 유지하는데 중요한
역할을 한다. 아토피피부염에서 지속적 또는 반복적인 피부장벽기능의 손상은
아토피행진을 통하여 호흡기 알레르기로 이행되는 첫 단계이다. 저자는
Oxazolone(Ox)이 반복 도포된 무모마우스, NC/Nga 마우스, Flaky tail 
마우스와 같은 세 종류의 아토피피부염 동물모델에 집먼지진드기의 한가지인
Dermatofagoides pteronyssinus (Dp)를 피부에 도포하고 흡입시켜서
아토피행진 동물모델을 만들 수 있는지, 이 동물모델의 각질층에 산성크림을
지속적으로 도포하여 적절한 산성환경을 유지하였을 경우에, 아토피행진을
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효과적으로 예방할 수 있는지에 대한 연구를 진행하였다. 각질층의 산도를
유지하기 위하여 구연산과 수산화나트륨을 섞어서 만든 산성(pH2.8) 및
중성(pH7.4) 크림을 아토피행진 동물모델에 하루 두번씩 도포하였다. Dp를
반복적으로 도포시킨 후 흡입시킨 아토피피부염 동물모델에서
호흡기알레르기가 발생하였다. 산성크림을 도포하여 각질층의 산도를
유지하자 아토피행진을 예방하는 효과를 얻었고, 중성크림을 도포하였을 때는
이를 더욱 악화되는 결과를 보였다. 결론적으로 Oxazolone을 반복 도포한
무모마우스, NC/Nga 마우스, Flaky tail 마우스와 같은 아토피피부염
동물모델에 지속적으로 Dp를 국소도포하고 흡입시켜서 아토피행진 동물모델을
만들 수 있으며, 각질층의 산도를 적절하게 유지하는 방법으로 아토피행진을
효과적으로 억제할 수 있었다.
                                                                                                                                                     
핵심 되는 말: 아토피행진, 호흡기 알레르기, 아토피피부염, Flaky tail 
마우스, NC/Nga 마우스, Oxazolone, 집먼지진드기
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